Status:
COMPLETED
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
Lead Sponsor:
University of Utah
Collaborating Sponsors:
Pfizer
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
We will determine if linezolid inhibits cellular activation and production of pro-inflammatory cytokines, providing mechanistic rationale for its clinical efficacy and the justification for further in...
Eligibility Criteria
Inclusion
- Healthy, taking no medications, and not recently hospitalized
Exclusion
- Infection (active)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00811980
Start Date
January 1 2009
End Date
June 1 2010
Last Update
November 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.